Which imaging modalities are primarily used in the Melanoma Diagnostic Radiopharmaceuticals Market?

The primary imaging modalities used in the Melanoma Diagnostic Radiopharmaceuticals Market are PET Scan and SPECT Scan. Read More

What are the key applications of Melanoma Diagnostic Radiopharmaceuticals?

The key applications of Melanoma Diagnostic Radiopharmaceuticals include Primary Melanoma Diagnosis, Metastasis Detection, Treatment Response Assessment, and Prognosis Determination. Read More

Which companies are considered key players in the Melanoma Diagnostic Radiopharmaceuticals Market?

Key players in the Melanoma Diagnostic Radiopharmaceuticals Market include Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Eli Lilly and Company, Merck & Co., Inc., AstraZeneca PLC, Pfizer Inc., and Siemens Healthineers AG. Read More

What is the projected market size for Diagnostic Imaging Centers by 2035?

The projected market size for Diagnostic Imaging Centers by 2035 is 2.05 USD Billion. Read More

How does the market size for hospitals compare to that of research institutions in 2035?

In 2035, the market size for hospitals is projected to be 2.45 USD Billion, whereas research institutions are expected to reach 1.68 USD Billion. Read More

What is the expected market performance for 99mTc-sestamibi in the coming years?

The expected market performance for 99mTc-sestamibi indicates a growth from 0.14 USD Billion in 2024 to 0.82 USD Billion by 2035. Read More

Melanoma Diagnostic Radiopharmaceuticals Market

Q: What is the projected market valuation for the Melanoma Diagnostic Radiopharmaceuticals Market in 2035?

The projected market valuation for the Melanoma Diagnostic Radiopharmaceuticals Market in 2035 is 6.106 USD Billion. Read More

Q: What was the market valuation for the Melanoma Diagnostic Radiopharmaceuticals Market in 2024?

The market valuation for the Melanoma Diagnostic Radiopharmaceuticals Market in 2024 was 1.05 USD Billion. Read More

Q: What is the expected CAGR for the Melanoma Diagnostic Radiopharmaceuticals Market during the forecast period 2025 - 2035?

The expected CAGR for the Melanoma Diagnostic Radiopharmaceuticals Market during the forecast period 2025 - 2035 is 17.35%. Read More

Q: What was the market size for 18F-FDG in the Melanoma Diagnostic Radiopharmaceuticals Market in 2024?

The market size for 18F-FDG in the Melanoma Diagnostic Radiopharmaceuticals Market in 2024 was 0.42 USD Billion. Read More

ID: MRFR/MED/26091-HCR

100 Pages

Rahul Gotadki

Last Updated: April 06, 2026

Melanoma Diagnostic Radiopharmaceuticals Market Research Report By Product (18F-FDG, 18F-DOPA, 99mTc-sestamibi, 123I-metaiodobenzylguanidine (MIBG), 11C-choline), By Application (Primary Melanoma Diagnosis, Metastasis Detection, Treatment Response Assessment, Prognosis Determination), By End-User (Hospitals, Diagnostic Imaging Centers, Research Institutions), By Imaging Modality (PET Scan, SPECT Scan) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Melanoma Diagnostic Radiopharmaceuticals Market Infographic

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Product (USD Billion)
  1. 4.1.1 18F-FDG
  2. 4.1.2 18F-DOPA
  3. 4.1.3 99mTc-sestamibi
  4. 4.1.4 123I-metaiodobenzylguanidine (MIBG)
  5. 4.1.5 11C-choline
2. 4.2 Healthcare, BY Application (USD Billion)
  1. 4.2.1 Primary Melanoma Diagnosis
  2. 4.2.2 Metastasis Detection
  3. 4.2.3 Treatment Response Assessment
  4. 4.2.4 Prognosis Determination
3. 4.3 Healthcare, BY End-User (USD Billion)
  1. 4.3.1 Hospitals
  2. 4.3.2 Diagnostic Imaging Centers
  3. 4.3.3 Research Institutions
4. 4.4 Healthcare, BY Imaging Modality (USD Billion)
  1. 4.4.1 PET Scan
  2. 4.4.2 SPECT Scan
5. 4.5 Healthcare, BY Region (USD Billion)
  1. 4.5.1 North America
    1. 4.5.1.1 US
    2. 4.5.1.2 Canada
  2. 4.5.2 Europe
    1. 4.5.2.1 Germany
    2. 4.5.2.2 UK
    3. 4.5.2.3 France
    4. 4.5.2.4 Russia
    5. 4.5.2.5 Italy
    6. 4.5.2.6 Spain
    7. 4.5.2.7 Rest of Europe
  3. 4.5.3 APAC
    1. 4.5.3.1 China
    2. 4.5.3.2 India
    3. 4.5.3.3 Japan
    4. 4.5.3.4 South Korea
    5. 4.5.3.5 Malaysia
    6. 4.5.3.6 Thailand
    7. 4.5.3.7 Indonesia
    8. 4.5.3.8 Rest of APAC
  4. 4.5.4 South America
    1. 4.5.4.1 Brazil
    2. 4.5.4.2 Mexico
    3. 4.5.4.3 Argentina
    4. 4.5.4.4 Rest of South America
  5. 4.5.5 MEA
    1. 4.5.5.1 GCC Countries
    2. 4.5.5.2 South Africa
    3. 4.5.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Bayer AG (DE)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Novartis AG (CH)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Bristol-Myers Squibb Company (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Eli Lilly and Company (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Merck & Co., Inc. (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 AstraZeneca PLC (GB)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Pfizer Inc. (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Siemens Healthineers AG (DE)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY PRODUCT
4. 6.4 US MARKET ANALYSIS BY APPLICATION
5. 6.5 US MARKET ANALYSIS BY END-USER
6. 6.6 US MARKET ANALYSIS BY IMAGING MODALITY
7. 6.7 CANADA MARKET ANALYSIS BY PRODUCT
8. 6.8 CANADA MARKET ANALYSIS BY APPLICATION
9. 6.9 CANADA MARKET ANALYSIS BY END-USER
10. 6.10 CANADA MARKET ANALYSIS BY IMAGING MODALITY
11. 6.11 EUROPE MARKET ANALYSIS
12. 6.12 GERMANY MARKET ANALYSIS BY PRODUCT
13. 6.13 GERMANY MARKET ANALYSIS BY APPLICATION
14. 6.14 GERMANY MARKET ANALYSIS BY END-USER
15. 6.15 GERMANY MARKET ANALYSIS BY IMAGING MODALITY
16. 6.16 UK MARKET ANALYSIS BY PRODUCT
17. 6.17 UK MARKET ANALYSIS BY APPLICATION
18. 6.18 UK MARKET ANALYSIS BY END-USER
19. 6.19 UK MARKET ANALYSIS BY IMAGING MODALITY
20. 6.20 FRANCE MARKET ANALYSIS BY PRODUCT
21. 6.21 FRANCE MARKET ANALYSIS BY APPLICATION
22. 6.22 FRANCE MARKET ANALYSIS BY END-USER
23. 6.23 FRANCE MARKET ANALYSIS BY IMAGING MODALITY
24. 6.24 RUSSIA MARKET ANALYSIS BY PRODUCT
25. 6.25 RUSSIA MARKET ANALYSIS BY APPLICATION
26. 6.26 RUSSIA MARKET ANALYSIS BY END-USER
27. 6.27 RUSSIA MARKET ANALYSIS BY IMAGING MODALITY
28. 6.28 ITALY MARKET ANALYSIS BY PRODUCT
29. 6.29 ITALY MARKET ANALYSIS BY APPLICATION
30. 6.30 ITALY MARKET ANALYSIS BY END-USER
31. 6.31 ITALY MARKET ANALYSIS BY IMAGING MODALITY
32. 6.32 SPAIN MARKET ANALYSIS BY PRODUCT
33. 6.33 SPAIN MARKET ANALYSIS BY APPLICATION
34. 6.34 SPAIN MARKET ANALYSIS BY END-USER
35. 6.35 SPAIN MARKET ANALYSIS BY IMAGING MODALITY
36. 6.36 REST OF EUROPE MARKET ANALYSIS BY PRODUCT
37. 6.37 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
38. 6.38 REST OF EUROPE MARKET ANALYSIS BY END-USER
39. 6.39 REST OF EUROPE MARKET ANALYSIS BY IMAGING MODALITY
40. 6.40 APAC MARKET ANALYSIS
41. 6.41 CHINA MARKET ANALYSIS BY PRODUCT
42. 6.42 CHINA MARKET ANALYSIS BY APPLICATION
43. 6.43 CHINA MARKET ANALYSIS BY END-USER
44. 6.44 CHINA MARKET ANALYSIS BY IMAGING MODALITY
45. 6.45 INDIA MARKET ANALYSIS BY PRODUCT
46. 6.46 INDIA MARKET ANALYSIS BY APPLICATION
47. 6.47 INDIA MARKET ANALYSIS BY END-USER
48. 6.48 INDIA MARKET ANALYSIS BY IMAGING MODALITY
49. 6.49 JAPAN MARKET ANALYSIS BY PRODUCT
50. 6.50 JAPAN MARKET ANALYSIS BY APPLICATION
51. 6.51 JAPAN MARKET ANALYSIS BY END-USER
52. 6.52 JAPAN MARKET ANALYSIS BY IMAGING MODALITY
53. 6.53 SOUTH KOREA MARKET ANALYSIS BY PRODUCT
54. 6.54 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
55. 6.55 SOUTH KOREA MARKET ANALYSIS BY END-USER
56. 6.56 SOUTH KOREA MARKET ANALYSIS BY IMAGING MODALITY
57. 6.57 MALAYSIA MARKET ANALYSIS BY PRODUCT
58. 6.58 MALAYSIA MARKET ANALYSIS BY APPLICATION
59. 6.59 MALAYSIA MARKET ANALYSIS BY END-USER
60. 6.60 MALAYSIA MARKET ANALYSIS BY IMAGING MODALITY
61. 6.61 THAILAND MARKET ANALYSIS BY PRODUCT
62. 6.62 THAILAND MARKET ANALYSIS BY APPLICATION
63. 6.63 THAILAND MARKET ANALYSIS BY END-USER
64. 6.64 THAILAND MARKET ANALYSIS BY IMAGING MODALITY
65. 6.65 INDONESIA MARKET ANALYSIS BY PRODUCT
66. 6.66 INDONESIA MARKET ANALYSIS BY APPLICATION
67. 6.67 INDONESIA MARKET ANALYSIS BY END-USER
68. 6.68 INDONESIA MARKET ANALYSIS BY IMAGING MODALITY
69. 6.69 REST OF APAC MARKET ANALYSIS BY PRODUCT
70. 6.70 REST OF APAC MARKET ANALYSIS BY APPLICATION
71. 6.71 REST OF APAC MARKET ANALYSIS BY END-USER
72. 6.72 REST OF APAC MARKET ANALYSIS BY IMAGING MODALITY
73. 6.73 SOUTH AMERICA MARKET ANALYSIS
74. 6.74 BRAZIL MARKET ANALYSIS BY PRODUCT
75. 6.75 BRAZIL MARKET ANALYSIS BY APPLICATION
76. 6.76 BRAZIL MARKET ANALYSIS BY END-USER
77. 6.77 BRAZIL MARKET ANALYSIS BY IMAGING MODALITY
78. 6.78 MEXICO MARKET ANALYSIS BY PRODUCT
79. 6.79 MEXICO MARKET ANALYSIS BY APPLICATION
80. 6.80 MEXICO MARKET ANALYSIS BY END-USER
81. 6.81 MEXICO MARKET ANALYSIS BY IMAGING MODALITY
82. 6.82 ARGENTINA MARKET ANALYSIS BY PRODUCT
83. 6.83 ARGENTINA MARKET ANALYSIS BY APPLICATION
84. 6.84 ARGENTINA MARKET ANALYSIS BY END-USER
85. 6.85 ARGENTINA MARKET ANALYSIS BY IMAGING MODALITY
86. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT
87. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
88. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY END-USER
89. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY IMAGING MODALITY
90. 6.90 MEA MARKET ANALYSIS
91. 6.91 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT
92. 6.92 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
93. 6.93 GCC COUNTRIES MARKET ANALYSIS BY END-USER
94. 6.94 GCC COUNTRIES MARKET ANALYSIS BY IMAGING MODALITY
95. 6.95 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT
96. 6.96 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
97. 6.97 SOUTH AFRICA MARKET ANALYSIS BY END-USER
98. 6.98 SOUTH AFRICA MARKET ANALYSIS BY IMAGING MODALITY
99. 6.99 REST OF MEA MARKET ANALYSIS BY PRODUCT
100. 6.100 REST OF MEA MARKET ANALYSIS BY APPLICATION
101. 6.101 REST OF MEA MARKET ANALYSIS BY END-USER
102. 6.102 REST OF MEA MARKET ANALYSIS BY IMAGING MODALITY
103. 6.103 KEY BUYING CRITERIA OF HEALTHCARE
104. 6.104 RESEARCH PROCESS OF MRFR
105. 6.105 DRO ANALYSIS OF HEALTHCARE
106. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
107. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
108. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
109. 6.109 HEALTHCARE, BY PRODUCT, 2024 (% SHARE)
110. 6.110 HEALTHCARE, BY PRODUCT, 2024 TO 2035 (USD Billion)
111. 6.111 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
112. 6.112 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
113. 6.113 HEALTHCARE, BY END-USER, 2024 (% SHARE)
114. 6.114 HEALTHCARE, BY END-USER, 2024 TO 2035 (USD Billion)
115. 6.115 HEALTHCARE, BY IMAGING MODALITY, 2024 (% SHARE)
116. 6.116 HEALTHCARE, BY IMAGING MODALITY, 2024 TO 2035 (USD Billion)
117. 6.117 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.2.3 BY END-USER, 2025-2035 (USD Billion)
  4. 7.2.4 BY IMAGING MODALITY, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.3.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.3.3 BY END-USER, 2025-2035 (USD Billion)
  4. 7.3.4 BY IMAGING MODALITY, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.4.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.4.3 BY END-USER, 2025-2035 (USD Billion)
  4. 7.4.4 BY IMAGING MODALITY, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.5.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.5.3 BY END-USER, 2025-2035 (USD Billion)
  4. 7.5.4 BY IMAGING MODALITY, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.6.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.6.3 BY END-USER, 2025-2035 (USD Billion)
  4. 7.6.4 BY IMAGING MODALITY, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.7.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.7.3 BY END-USER, 2025-2035 (USD Billion)
  4. 7.7.4 BY IMAGING MODALITY, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.8.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.8.3 BY END-USER, 2025-2035 (USD Billion)
  4. 7.8.4 BY IMAGING MODALITY, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.9.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.9.3 BY END-USER, 2025-2035 (USD Billion)
  4. 7.9.4 BY IMAGING MODALITY, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.10.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.10.3 BY END-USER, 2025-2035 (USD Billion)
  4. 7.10.4 BY IMAGING MODALITY, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.11.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.11.3 BY END-USER, 2025-2035 (USD Billion)
  4. 7.11.4 BY IMAGING MODALITY, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.12.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.12.3 BY END-USER, 2025-2035 (USD Billion)
  4. 7.12.4 BY IMAGING MODALITY, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.13.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.13.3 BY END-USER, 2025-2035 (USD Billion)
  4. 7.13.4 BY IMAGING MODALITY, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.14.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.14.3 BY END-USER, 2025-2035 (USD Billion)
  4. 7.14.4 BY IMAGING MODALITY, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.15.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.15.3 BY END-USER, 2025-2035 (USD Billion)
  4. 7.15.4 BY IMAGING MODALITY, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.16.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.16.3 BY END-USER, 2025-2035 (USD Billion)
  4. 7.16.4 BY IMAGING MODALITY, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.17.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.17.3 BY END-USER, 2025-2035 (USD Billion)
  4. 7.17.4 BY IMAGING MODALITY, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.18.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.18.3 BY END-USER, 2025-2035 (USD Billion)
  4. 7.18.4 BY IMAGING MODALITY, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.19.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.19.3 BY END-USER, 2025-2035 (USD Billion)
  4. 7.19.4 BY IMAGING MODALITY, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.20.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.20.3 BY END-USER, 2025-2035 (USD Billion)
  4. 7.20.4 BY IMAGING MODALITY, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.21.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.21.3 BY END-USER, 2025-2035 (USD Billion)
  4. 7.21.4 BY IMAGING MODALITY, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.22.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.22.3 BY END-USER, 2025-2035 (USD Billion)
  4. 7.22.4 BY IMAGING MODALITY, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.23.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.23.3 BY END-USER, 2025-2035 (USD Billion)
  4. 7.23.4 BY IMAGING MODALITY, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.24.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.24.3 BY END-USER, 2025-2035 (USD Billion)
  4. 7.24.4 BY IMAGING MODALITY, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.25.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.25.3 BY END-USER, 2025-2035 (USD Billion)
  4. 7.25.4 BY IMAGING MODALITY, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.26.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.26.3 BY END-USER, 2025-2035 (USD Billion)
  4. 7.26.4 BY IMAGING MODALITY, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.27.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.27.3 BY END-USER, 2025-2035 (USD Billion)
  4. 7.27.4 BY IMAGING MODALITY, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.28.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.28.3 BY END-USER, 2025-2035 (USD Billion)
  4. 7.28.4 BY IMAGING MODALITY, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.29.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.29.3 BY END-USER, 2025-2035 (USD Billion)
  4. 7.29.4 BY IMAGING MODALITY, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY PRODUCT, 2025-2035 (USD Billion)
  2. 7.30.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.30.3 BY END-USER, 2025-2035 (USD Billion)
  4. 7.30.4 BY IMAGING MODALITY, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Healthcare Market Segmentation

Healthcare By Product (USD Billion, 2025-2035)

18F-FDG
18F-DOPA
99mTc-sestamibi
123I-metaiodobenzylguanidine (MIBG)
11C-choline

Healthcare By Application (USD Billion, 2025-2035)

Primary Melanoma Diagnosis
Metastasis Detection
Treatment Response Assessment
Prognosis Determination

Healthcare By End-User (USD Billion, 2025-2035)

Hospitals
Diagnostic Imaging Centers
Research Institutions

Healthcare By Imaging Modality (USD Billion, 2025-2035)

PET Scan
SPECT Scan

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓